Open Access
Open access
том 373 издание 6556

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants

Тип публикацииJournal Article
Дата публикации2021-08-13
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR10.948
CiteScore44.6
Impact factor47.3
ISSN00368075, 10959203
Multidisciplinary
Краткое описание
Defenses against SARS-CoV-2 variants

Our key defense against the COVID-19 pandemic is neutralizing antibodies against the SARS-CoV-2 virus elicited by natural infection or vaccination. Recent emerging viral variants have raised concern because of their potential to escape antibody neutralization. Wang et al . identified four antibodies from early-outbreak convalescent donors that are potent against 23 variants, including variants of concern, and characterized their binding to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Yuan et al . examined the impact of emerging mutations in the receptor-binding domain of the spike protein on binding to the host receptor ACE2 and to a range of antibodies. These studies may be helpful for developing more broadly effective vaccines and therapeutic antibodies. —VV

Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

5
10
15
20
25
30
35
bioRxiv
35 публикаций, 19.13%
Nature Communications
8 публикаций, 4.37%
Frontiers in Immunology
8 публикаций, 4.37%
Science
6 публикаций, 3.28%
PLoS Pathogens
5 публикаций, 2.73%
Science Translational Medicine
5 публикаций, 2.73%
Viruses
4 публикации, 2.19%
iScience
4 публикации, 2.19%
Cell
3 публикации, 1.64%
Nature Immunology
3 публикации, 1.64%
Cell Reports
3 публикации, 1.64%
Immunity
3 публикации, 1.64%
International Journal of Biological Macromolecules
3 публикации, 1.64%
Science immunology
3 публикации, 1.64%
medRxiv
3 публикации, 1.64%
International Journal of Molecular Sciences
2 публикации, 1.09%
Biomolecules
2 публикации, 1.09%
npj Vaccines
2 публикации, 1.09%
Cell Research
2 публикации, 1.09%
Nature
2 публикации, 1.09%
Signal Transduction and Targeted Therapy
2 публикации, 1.09%
Structure
2 публикации, 1.09%
Cell Host and Microbe
2 публикации, 1.09%
PLoS ONE
2 публикации, 1.09%
Journal of Medical Virology
2 публикации, 1.09%
Journal of Experimental Medicine
2 публикации, 1.09%
Journal of Virology
2 публикации, 1.09%
Science advances
2 публикации, 1.09%
Current Pharmaceutical Design
1 публикация, 0.55%
Biochemical Society Transactions
1 публикация, 0.55%
5
10
15
20
25
30
35

Издатели

5
10
15
20
25
30
35
40
Elsevier
39 публикаций, 21.31%
openRxiv
38 публикаций, 20.77%
Springer Nature
30 публикаций, 16.39%
American Association for the Advancement of Science (AAAS)
16 публикаций, 8.74%
MDPI
14 публикаций, 7.65%
Frontiers Media S.A.
9 публикаций, 4.92%
Public Library of Science (PLoS)
8 публикаций, 4.37%
Wiley
8 публикаций, 4.37%
American Chemical Society (ACS)
4 публикации, 2.19%
Taylor & Francis
3 публикации, 1.64%
American Society for Microbiology
3 публикации, 1.64%
Bentham Science Publishers Ltd.
2 публикации, 1.09%
Oxford University Press
2 публикации, 1.09%
Rockefeller University Press
2 публикации, 1.09%
Portland Press
1 публикация, 0.55%
LLC Numicom
1 публикация, 0.55%
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 0.55%
Annual Reviews
1 публикация, 0.55%
Ovid Technologies (Wolters Kluwer) - Medknow Publications
1 публикация, 0.55%
5
10
15
20
25
30
35
40
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
183
Поделиться
Цитировать
ГОСТ |
Цитировать
Wang L. et al. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants // Science. 2021. Vol. 373. No. 6556.
ГОСТ со всеми авторами (до 50) Скопировать
Wang L. et al. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants // Science. 2021. Vol. 373. No. 6556.
RIS |
Цитировать
TY - JOUR
DO - 10.1126/science.abh1766
UR - https://doi.org/10.1126/science.abh1766
TI - Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
T2 - Science
AU - Wang, Lingshu
AU - Zhou, Tongqing
AU - Zhang, Yi
AU - Yang, Eun-Sung
AU - Schramm, Chaim A
AU - Shi, Wei
AU - Pegu, Amarendra
AU - Oloniniyi, Olamide K
AU - Henry, Amy R.
AU - Darko, Samuel N.
AU - Narpala, Sandeep
AU - Hatcher, Christian
AU - Martinez, David G.
AU - Tsybovsky, Yaroslav
AU - Phung, Emily
AU - Abiona, Olubukola M.
AU - Antia, Avan
AU - Cale, Evan M.
AU - Chang, Lauren
AU - Choe, Misook
AU - Corbett, Kizzmekia S.
AU - Davis, Rachel L
AU - DiPiazza, Anthony T.
AU - Gordon, Ingelise J.
AU - Helmold Hait, Sabrina
AU - Hermanus, Tandile
AU - Kgagudi, Prudence
AU - Laboune, Farida
AU - Leung, Kwanyee
AU - Liu, Tracy
AU - Mason, Rosemarie
AU - Nazzari, Alexandra F
AU - Novik, Laura
AU - O’Connell, Sarah
AU - O'Dell, Sijy
AU - Olia, Adam S
AU - Schmidt, Stephen P.
AU - Stephens, Tyler
AU - Stringham, Christopher D
AU - Talana, Chloe Adrienna
AU - Teng, I-Ting
AU - Wagner, John A
AU - Widge, Alicia
AU - Zhang, Baoshan
AU - Roederer, Mario
AU - Ledgerwood, Julie E.
AU - Ruckwardt, Tracy J.
AU - Gaudinski, Martin R.
AU - Moore, Penny
AU - Doria-Rose, N.
AU - Baric, Ralph
AU - Graham, B.
AU - McDermott, Adrian B.
AU - Douek, Daniel C.
AU - Kwong, Peter D.
AU - Mascola, John
AU - Sullivan, Nancy J
AU - Misasi, John
PY - 2021
DA - 2021/08/13
PB - American Association for the Advancement of Science (AAAS)
IS - 6556
VL - 373
PMID - 34210892
SN - 0036-8075
SN - 1095-9203
ER -
BibTex
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2021_Wang,
author = {Lingshu Wang and Tongqing Zhou and Yi Zhang and Eun-Sung Yang and Chaim A Schramm and Wei Shi and Amarendra Pegu and Olamide K Oloniniyi and Amy R. Henry and Samuel N. Darko and Sandeep Narpala and Christian Hatcher and David G. Martinez and Yaroslav Tsybovsky and Emily Phung and Olubukola M. Abiona and Avan Antia and Evan M. Cale and Lauren Chang and Misook Choe and Kizzmekia S. Corbett and Rachel L Davis and Anthony T. DiPiazza and Ingelise J. Gordon and Sabrina Helmold Hait and Tandile Hermanus and Prudence Kgagudi and Farida Laboune and Kwanyee Leung and Tracy Liu and Rosemarie Mason and Alexandra F Nazzari and Laura Novik and Sarah O’Connell and Sijy O'Dell and Adam S Olia and Stephen P. Schmidt and Tyler Stephens and Christopher D Stringham and Chloe Adrienna Talana and I-Ting Teng and John A Wagner and Alicia Widge and Baoshan Zhang and Mario Roederer and Julie E. Ledgerwood and Tracy J. Ruckwardt and Martin R. Gaudinski and Penny Moore and N. Doria-Rose and others},
title = {Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants},
journal = {Science},
year = {2021},
volume = {373},
publisher = {American Association for the Advancement of Science (AAAS)},
month = {aug},
url = {https://doi.org/10.1126/science.abh1766},
number = {6556},
doi = {10.1126/science.abh1766}
}
Ошибка в публикации?